Cargando…

Diabetes Mellitus and Younger Age Are Risk Factors for Hyperphosphatemia in Peritoneal Dialysis Patients

Hyperphosphatemia has been associated with adverse outcomes in patients with end stage kidney disease (ESKD). The purpose of this study was to determine risk factors for hyperphosphatemia in ESKD patients treated with peritoneal dialysis (PD). This information will be used to develop a patient speci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imtiaz, Rameez, Hawken, Steven, McCormick, Brendan B., Leung, Simon, Hiremath, Swapnil, Zimmerman, Deborah L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331583/ https://www.ncbi.nlm.nih.gov/pubmed/28218647 http://dx.doi.org/10.3390/nu9020152

Ejemplares similares

Physical Activity in Patients Treated With Peritoneal Dialysis: A Systematic Review and Meta-analysis
por: Thangarasa, Tharshika, et al.
Publicado: (2018)

Physical Activity in Patients Treated With Peritoneal Dialysis: A Protocol for a Systematic Review
por: Thangarasa, Tharshika, et al.
Publicado: (2017)

Meal phosphate variability does not support fixed dose phosphate binder schedules for patients treated with peritoneal dialysis: a prospective cohort study
por: Leung, Simon, et al.
Publicado: (2015)

Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients
por: Langote, Amit, et al.
Publicado: (2017)

Microparticle Formation in Peritoneal Dialysis: A Proof of Concept Study
por: Akbari, Shareef, et al.
Publicado: (2017)

Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients
por: Shang, Da, et al.
Publicado: (2017)

Hyperphosphatemia as an independent risk factor for coronary artery calcification progression in peritoneal dialysis patients
por: Shang, Da, et al.
Publicado: (2015)

Use of Nicotinamide to Treat Hyperphosphatemia in Dialysis Patients
por: Lenglet, Aurélie, et al.
Publicado: (2013)

Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: A cross-sectional study
por: Yin, Xiaojing, et al.
Publicado: (2023)

A Diagnostic Dilemma “Cured” by Dialysis: An Educational Case Report
por: Chan, Ryan J., et al.
Publicado: (2023)

Pre-Peritoneal Dialysis Peritonitis After Saline Infusion Sonohysterogram in a Patient With an Embedded Catheter: A Case Report
por: Cosmatos, Alexandre, et al.
Publicado: (2023)

Successful Initiation of Dialysis with a 20-Year-Old Buried Peritoneal Dialysis Catheter: Case Report and Literature Review
por: Gupta, Ankur, et al.
Publicado: (2019)

Lower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study
por: Molnar, Amber O., et al.
Publicado: (2017)

Corrigendum: Prevalence and factors associated with hyperphosphatemia in continuous ambulatory peritoneal dialysis patients: a cross-sectional study
por: Yin, Xiaojing, et al.
Publicado: (2023)

Canadian Society of Nephrology COVID-19 Rapid Response Team Home Dialysis Recommendations
por: Copland, Michael, et al.
Publicado: (2020)

Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients
por: Shin, Sooyoung, et al.
Publicado: (2014)

A Dialysis Patient With Hyperphosphatemia, Hyperkalemia, and Azotemia Without an Excessive Intake
por: Fukuoka, Kazuhito, et al.
Publicado: (2017)

Tenapanor as Add-on Treatment for Hyperphosphatemia in Dialysis Patients: Enough Bang for the Buck?
por: Wish, Jay B.
Publicado: (2023)

Lanthanum carbonate versus placebo for management of hyperphosphatemia in patients undergoing peritoneal dialysis: a subgroup analysis of a phase 2 randomized controlled study of dialysis patients
por: Hutchison, Alastair J, et al.
Publicado: (2013)

Nicotinic acid and related compounds: A meta-analysis of their use for hyperphosphatemia in dialysis patients
por: Liu, Xianhua, et al.
Publicado: (2018)

Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study
por: Kim, Hyunsuk, et al.
Publicado: (2015)

Hyperphosphatemia and Cardiovascular Disease
por: Zhou, Chao, et al.
Publicado: (2021)

Aging of the Peritoneal Dialysis Membrane
por: Krediet, Raymond T.
Publicado: (2022)

Tenapanor Improves Long-Term Control of Hyperphosphatemia in Patients Receiving Maintenance Dialysis: the NORMALIZE Study
por: Silva, Arnold L., et al.
Publicado: (2023)

Peritoneal Adipocytes and Their Role in Inflammation during Peritoneal Dialysis
por: Lai, Kar Neng, et al.
Publicado: (2010)

Thiazide diuretic-caused hyponatremia in the elderly hypertensive: will a bottle of Nepro a day keep hyponatremia and the doctor away? Study protocol for a proof-of-concept feasibility trial
por: Ruzicka, Marcel, et al.
Publicado: (2018)

Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients
por: Streja, Elani, et al.
Publicado: (2013)

Corrigendum: Aging of the Peritoneal Dialysis Membrane
por: Krediet, Raymond T.
Publicado: (2022)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

Age, diabetes mellitus, and dialysis modality are associated with risk of poor muscle strength and physical function in hemodialysis and peritoneal dialysis patients
por: Silva, Maryanne Zilli Canedo, et al.
Publicado: (2021)

Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis
por: Ma, Terry King-Wing, et al.
Publicado: (2016)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

Peritoneal dialysis: increasing global utilization as an option for renal replacement therapy
por: Zimmerman, Anna M
Publicado: (2019)

Effect of Intradialytic Exercise on Hyperphosphatemia and Malnutrition
por: Salhab, Nada, et al.
Publicado: (2019)

Control of hyperphosphatemia and maintenance of calcemia in CKD
por: Carvalho, Aluizio Barbosa, et al.
Publicado: (2021)

Phosphate intake, hyperphosphatemia, and kidney function
por: Rubio-Aliaga, Isabel, et al.
Publicado: (2022)

Should the Arteriovenous Fistula Be Created before Starting Dialysis?: A Decision Analytic Approach
por: Hiremath, Swapnil, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_1hl7cge7gq3j0cbtmedoe2qk77